Fisher Wallace Laboratories, Inc. — Form D
Fisher Wallace Laboratories, Inc. of BROOKLYN, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-26. The offering totals $750K, of which $250K was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-07-26
- Form: D
- Accession: 0001787792-22-000001
- Industry: Other Technology
- Exemptions: 06c
- Total offering: $750K
- Amount sold: $250K
- Remaining: $500K
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2022-07-03
- Security types: debt
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-453724
Issuer
- Name: Fisher Wallace Laboratories, Inc.
- CIK: 0001787792
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 630 FLUSHING AVENUE, BOX 104, BROOKLYN, NY, 11206
- Phone: 917-930-4332
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Charles Fisher | Director | San Francisco, CA |
| Kelly Roman | Director | Brooklyn, NY |
| Simon Webster | Director | Jersey, Y7 |
| Charles Fisher | Executive Officer | San Francisco, CA |
| Kelly Roman | Executive Officer | Brooklyn, NY |
| Kelly Joseph Roman | Director | BROOKLYN, NY |
| Kelly Joseph Roman | Executive Officer | BROOKLYN, NY |
| Charles Avery Fisher | Director | BROOKLYN, NY |
Other filings by this issuer (1)
More